Clarivate (CLVT) Stock Price, News & Analysis

-0.17 (-2.75%)
(As of 05/17/2024 ET)
Today's Range
50-Day Range
52-Week Range
5.92 million shs
Average Volume
4.44 million shs
Market Capitalization
$4.02 billion
P/E Ratio
Dividend Yield
Price Target

Clarivate MarketRank™ Stock Analysis

Analyst Rating
2.00 Rating Score
29.4% Upside
$7.78 Price Target
Short Interest
11.83% of Float Sold Short
Dividend Strength
News Sentiment
0.63mentions of Clarivate in the last 14 days
Based on 6 Articles This Week
Insider Trading
Proj. Earnings Growth
From $0.62 to $0.68 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.54 out of 5 stars

Computer And Technology Sector

276th out of 590 stocks

Data Processing & Preparation Industry

23rd out of 57 stocks

CLVT stock logo

About Clarivate Stock (NYSE:CLVT)

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications. It also provides Patent and Trademark Renewals, that supports paralegal and admin tasks throughout the patent and trademark protection and maintenance process; CompuMark and Derwent, that supports critical decisions around patent and trademark protection, risk, and value creation throughout the innovation and brand lifecycle; IPFolio and Foundation IP that creates a structured environment for the protection and management of global patent and trademark assets. In addition, the company offers Cortellis Competitive Intelligence and Cortellis Drug Discovery Intelligence, that supports the development of new drugs and medical devices from discovery to clinical trials; Cortellis Regulatory Intelligence and OFF-X to monitor drug safety issues and adhere to regulatory protocols; Real World Data and Optimize that inform commercial launch strategy and set pricing for optimal reimbursement. It serves corporations, universities, law firms, government agencies, public libraries, and other professional services organizations. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.

CLVT Stock Price History

CLVT Stock News Headlines

OMRON Selects IPfolio from Clarivate
Clarivate Posts Loss In Q1; Reaffirms FY24 Outlook
Clarivate Reports First Quarter 2024 Results
Clarivate acquires Global QMS
Clarivate PLC Ordinary Shares
See More Headlines
Receive CLVT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Clarivate and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Industry, Sector and Symbol

Data processing & preparation
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
9 Analysts


Net Income
Pretax Margin


Sales & Book Value

Annual Sales
$2.63 billion
Cash Flow
$1.77 per share
Book Value
$6.73 per share


Free Float
Market Cap
$4.02 billion
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Mr. Jonathan Gear (Age 53)
    CEO & Director
    Comp: $1.9M
  • Mr. Jonathan M. Collins (Age 44)
    Executive VP & CFO
    Comp: $1.31M
  • Mr. Gordon Samson (Age 58)
    President of Intellectual Property
    Comp: $1.08M
  • Mr. Bar Veinstein (Age 51)
    President of Academia & Government
    Comp: $1.1M
  • Mr. Henry Levy (Age 51)
    President of Life Sciences & Healthcare
    Comp: $1.05M
  • Mr. Michael Easton (Age 51)
    Senior VP of Finance & Chief Accounting Officer
  • Mr. William E. Graff
    Executive VP & Chief Information Officer
  • Mr. Mark J. Donohue
    Head of Investor Relations
  • Ms. Melanie D. Margolin J.D. (Age 52)
    Chief Legal Officer & Secretary
  • Ms. Tabita Andersson
    Senior Vice President of Communications & Brand

CLVT Stock Analysis - Frequently Asked Questions

Should I buy or sell Clarivate stock right now?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Clarivate in the last twelve months. There are currently 3 sell ratings, 3 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" CLVT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CLVT, but not buy additional shares or sell existing shares.
View CLVT analyst ratings
or view top-rated stocks.

What is Clarivate's stock price target for 2024?

9 analysts have issued 12-month price targets for Clarivate's shares. Their CLVT share price targets range from $6.00 to $10.00. On average, they expect the company's share price to reach $7.78 in the next year. This suggests a possible upside of 29.4% from the stock's current price.
View analysts price targets for CLVT
or view top-rated stocks among Wall Street analysts.

How have CLVT shares performed in 2024?

Clarivate's stock was trading at $9.26 on January 1st, 2024. Since then, CLVT shares have decreased by 35.1% and is now trading at $6.01.
View the best growth stocks for 2024 here

Are investors shorting Clarivate?

Clarivate saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 43,830,000 shares, an increase of 14.9% from the April 15th total of 38,140,000 shares. Based on an average trading volume of 4,380,000 shares, the days-to-cover ratio is currently 10.0 days. Currently, 11.8% of the shares of the stock are sold short.
View Clarivate's Short Interest

When is Clarivate's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 1st 2024.
View our CLVT earnings forecast

How were Clarivate's earnings last quarter?

Clarivate Plc (NYSE:CLVT) announced its quarterly earnings results on Tuesday, February, 27th. The company reported $0.21 earnings per share for the quarter, meeting the consensus estimate of $0.21. The business had revenue of $683.70 million for the quarter, compared to the consensus estimate of $687.80 million. Clarivate had a negative net margin of 39.29% and a positive trailing twelve-month return on equity of 10.11%. The company's revenue for the quarter was up 1.2% compared to the same quarter last year. During the same period last year, the company earned $0.20 earnings per share.

What ETF holds Clarivate's stock?

Ranger Equity Bear ETF holds 130,000 shares of CLVT stock, representing -1.28% of its portfolio.

What guidance has Clarivate issued on next quarter's earnings?

Clarivate issued an update on its FY24 earnings guidance on Wednesday, May, 8th. The company provided earnings per share (EPS) guidance of $0.70-0.80 for the period, compared to the consensus earnings per share estimate of $0.74. The company issued revenue guidance of $2.57-2.67 billion, compared to the consensus revenue estimate of $2.62 billion.

Who are Clarivate's major shareholders?

Clarivate's stock is owned by many different retail and institutional investors. Top institutional shareholders include Exor N.V. (10.07%), Impactive Capital LP (5.67%), Baupost Group LLC MA (4.58%), Vanguard Group Inc. (1.21%), Invenomic Capital Management LP (0.96%) and Raymond James & Associates (0.91%). Insiders that own company stock include Andrew Miles Snyder, Blucher Sheryl G Von, Corp Onex, James Gordon Samson, Jeff Roy, Mukhtar Ahmed, Richard Hanks and Richard Roedel.
View institutional ownership trends

How do I buy shares of Clarivate?

Shares of CLVT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:CLVT) was last updated on 5/18/2024 by MarketBeat.com Staff

From Our Partners